Name | BIOTEKHNOLOGII-21 VEK, OOO |
|---|
INN | 7813392318 |
|---|
KPP | 781301001 |
|---|
OGRN | 1077847616296 |
|---|
OKPO | 82229086 |
|---|
Address | 197110, G.sankt-peterburg, ul. Pionerskaya, d. D. 30, of. OFIS 204 |
|---|
Phone | 294-61-94 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 72.19 | Core activity | Research and experimental development on natural sciences and engineering Other | | 46.12.31 | Additional activity | Involved in the sale of industrial and technical chemicals agents | | 46.75.2 | Additional activity | Wholesale of chemical products | | All types of activities | | 62.02 | Additional activity | Activities and advisory work in the field of computer technology | | 62.09 | Additional activity | Activities related to the usage of computers and information technology, other | | 70.22 | Additional activity | Advice on business and management | | 73.20.1 | Additional activity | Market and opinion research | | 95.11 | Additional activity | Repair of computers and peripheral computer equipment |
Registration date | 02.10.2007 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N15 po Sankt-Peterburgu |
|---|
|
BIOTEKHNOLOGII-21 VEK, OOO (Saint Petersburg; INN 7813392318) was registered on 2 Oct 2007. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of BIOTEKHNOLOGII-21 VEK, OOO - Limited liability companies. Form of ownership of BIOTEKHNOLOGII-21 VEK, OOO - Private property. Principal activities of BIOTEKHNOLOGII-21 VEK, OOO: research and experimental development on natural sciences and engineering other (72.19), involved in the sale of industrial and technical chemicals agents (46.12.31), wholesale of chemical products (46.75.2). |
Economic indicators2022
Net profit (RAS) of BIOTEKHNOLOGII-21 VEK, OOO dropped in 2022 by 39.63% to 879.00 thousand RUB from 1.46 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 2.54% to 11.03 million RUB from 11.32 million RUB in 2021; cost of goods sold grew 10.46 times to 4.83 million RUB from 462.00 thousand RUB; sales profit fell by 20.90% to 1.73 million RUB from 2.19 million RUB. 2021
Net profit (RAS) of BIOTEKHNOLOGII-21 VEK, OOO dropped in 2021 2.33 times to 1.46 million RUB from 3.40 million RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 43.25% to 11.32 million RUB from 19.95 million RUB in 2020; cost of goods sold decreased 4.71 times to 462.00 thousand RUB from 2.17 million RUB; sales profit went up by 3.50% to 2.19 million RUB from 2.12 million RUB. 2020
Net profit (RAS) of BIOTEKHNOLOGII-21 VEK, OOO made up 3.40 million RUB over 2020 compared to net loss of 1.45 million RUB over 2019, the company informed. Revenue decreased in the accounting period by 25.81% to 19.95 million RUB from 26.89 million RUB in 2019; cost of goods sold decreased 4.20 times to 2.17 million RUB from 9.13 million RUB; sales profit went up 28.23 times to 2.12 million RUB from 75.00 thousand RUB. 2019
Net loss (RA) of BIOTEKHNOLOGII-21 VEK, OOO made up 1.45 million RUB over 2019 compared to net profit of 10.36 million RUB over 2018, the company informed. Revenue decreased in the accounting period by 24.26% to 26.89 million RUB from 35.50 million RUB in 2018; cost of goods sold grew by 2.79% to 9.13 million RUB from 8.88 million RUB; sales profit fell 136.35 times to 75.00 thousand RUB from 10.23 million RUB. 2018
Net profit (RAS) of BIOTEKHNOLOGII-21 VEK, OOO grew over 2018 7.56 times to 10.36 million RUB from 1.37 million RUB over 2017, the company informed. Revenue decreased in the accounting period by 34.24% to 35.50 million RUB from 53.99 million RUB in 2017; cost of goods sold decreased 4.02 times to 8.88 million RUB from 35.68 million RUB; sales profit went up 4.32 times to 10.23 million RUB from 2.37 million RUB. 2017
Net profit (RAS) of BIOTEKHNOLOGII-21 VEK, OOO dropped in 2017 8.33 times to 1.37 million RUB from 11.41 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 4.43% to 53.99 million RUB from 56.49 million RUB in 2016; cost of goods sold grew by 20.85% to 35.68 million RUB from 29.53 million RUB; sales profit fell 5.10 times to 2.37 million RUB from 12.07 million RUB. 2016
Net profit (RAS) of BIOTEKHNOLOGII-21 VEK, OOO grew over 2016 6.80 times to 11.41 million RUB from 1.68 million RUB over 2015, the company informed. Revenue increased in the accounting period 4.16 times to 56.49 million RUB from 13.59 million RUB over 2015; cost of goods sold grew 2.54 times to 29.53 million RUB from 11.63 million RUB; sales profit went up 6.18 times to 12.07 million RUB from 1.95 million RUB. 2014
Net profit (RAS) of Biotekhnologii-21 vek, OOO made up 48.00 thousand RUB over 2014 compared to net loss of 78.00 thousand RUB over 2013, the company informed. Revenue decreased in the accounting period by 7.09% to 1.17 million RUB from 1.26 million RUB in 2013; cost of goods sold grew by 36.44% to 483.00 thousand RUB from 354.00 thousand RUB; sales profit made up 79.00 thousand RUB compared to sales loss of 37.00 thousand RUB. 2013
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|